|
|
Other links at Articles > Business of Medicine |
| 1. |
Genzyme Recalls Three Transplant Drug Lots: U.S. FDA
|
|
|
Genzyme Corp has voluntarily recalled three lots of Thymoglobulin, its injectable drug for transplant patients, after one lot failed a stability test, the U.S. Food and Drug Administration said on Thursday. Reuters Health Information
|
| 2. |
Francis Collins to Resign as NHGRI Director
|
|
|
After 15 years, Collins, who presided over the successful completion of the Human Genome Project, needs the time and opportunity to pursue other professional activities. Medscape Medical News
|
| 3. |
FDA Safety Changes: Cymbalta, Crestor, Rapamune
|
|
|
The FDA has approved revisions to the safety labeling for duloxetine HCl delayed-release capsules, rosuvastatin calcium tablets, and sirolimus tablets and oral solution. Medscape Medical News
|
| 4. |
U.S. Unveils Plan for Drug, Device Safety Tracking
|
|
|
U.S. health officials on Thursday announced plans for a new computer tracking system designed to help officials identify dangers from prescription drugs and medical devices after they reach the market. Reuters Health Information
|
|
|
